drugset / Trial / NCT02993315
Melanoma Patients Immunized with Natural DenDritic Cells
Phase 3
Completed
148 enrolled
Radboud University Medical Center
Dutch National Health Care Institute · collabZonMw: The Netherlands Organisation for Health Research and Development · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The aim of this study is to determine whether adjuvant treatment with nDC vaccination, after complete radical lymph node dissection or sentinel node procedure in stage IIIB and IIIC melanoma patients, improves recurrence-free survival (RFS) as compared to treatment with matching placebo.
Timeline
- Start
- 2016-10
- Primary completion
- 2024-01
- Completion
- 2024-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | nDC vaccination | Cell therapy | — | Other |